A 30-day case study by Dr. Lee Morgentaler of a 3CL protease cleanse with Tollovid, a 3CL protease inhibitor dietary supplement, in a patient who experienced Long Haulers Rebound following intervention with Pfizer’s Paxlovid.
Acute Sequelae of SARS-CoV-2 (PASC), also known as "Long Haulers", is a major public health problems. Emerging evidence suggests the PASC, for many, may in fact be due to persistent SARS-CoV-2 infection that is able to evade vaccine or infection-induced immunity and cause recurring and persistent symptoms. PASC does not appear to protect against new acute SARS-CoV-2 infection, and PASC may in fact contribute to poor outcomes in new acute infections and/or recurrent symptoms from prior infection.
Todos Medical reports a case of a patient with a history of multiple SARS-CoV-2 infections and persistent PASC, who received the therapeutic intervention Paxlovid following a positive PCR test and experienced severe rebound of symptoms starting on Day 5, the final day of Paxlovid treatment. The patient’s symptoms were resolved following an initial 14-day cleanse with 3CL protease inhibitor immune support dietary supplement Tollovid®.